Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Tobacco smoking, NBS1 polymorphisms, and survival in lung and upper aerodigestive tract cancers with semi-Bayes adjustment for hazard ratio variation.

Yang T, Chang PY, Park SL, Bastani D, Chang SC, Morgenstern H, Tashkin DP, Mao JT, Papp JC, Rao JY, Cozen W, Mack TM, Greenland S, Zhang ZF.

Cancer Causes Control. 2014 Jan;25(1):11-23. doi: 10.1007/s10552-013-0303-0. Epub 2013 Oct 29.

2.

Associations between NBS1 polymorphisms, haplotypes and smoking-related cancers.

Park SL, Bastani D, Goldstein BY, Chang SC, Cozen W, Cai L, Cordon-Cardo C, Ding B, Greenland S, He N, Hussain SK, Jiang Q, Lee YC, Liu S, Lu ML, Mack TM, Mao JT, Morgenstern H, Mu LN, Oh SS, Pantuck A, Papp JC, Rao J, Reuter VE, Tashkin DP, Wang H, You NC, Yu SZ, Zhao JK, Zhang ZF.

Carcinogenesis. 2010 Jul;31(7):1264-71. doi: 10.1093/carcin/bgq096. Epub 2010 May 17.

3.

Polymorphisms of peroxisome proliferator-activated receptors and survival of lung cancer and upper aero-digestive tract cancers.

Yang Y, Burke RV, Jeon CY, Chang SC, Chang PY, Morgenstern H, Tashkin DP, Mao J, Cozen W, Mack TM, Rao J, Zhang ZF.

Lung Cancer. 2014 Sep;85(3):449-56. doi: 10.1016/j.lungcan.2014.06.014. Epub 2014 Jun 27.

4.

A case-control study of the association of the polymorphisms and haplotypes of DNA ligase I with lung and upper-aerodigestive-tract cancers.

Lee YC, Morgenstern H, Greenland S, Tashkin DP, Papp J, Sinsheimer J, Cao W, Hashibe M, You NC, Mao JT, Cozen W, Mack TM, Zhang ZF.

Int J Cancer. 2008 Apr 1;122(7):1630-8.

5.

Genetic variants of NBS1 predict clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer in Chinese.

Xu JL, Hu LM, Huang MD, Zhao W, Yin YM, Hu ZB, Ma HX, Shen HB, Shu YQ.

Asian Pac J Cancer Prev. 2012;13(3):851-6.

6.

Alcohol dehydrogenase 3 genotype as a risk factor for upper aerodigestive tract cancers.

Nishimoto IN, Pinheiro NA, Rogatto SR, Carvalho AL, de Moura RP, Caballero OL, Simpson A, Kowalski LP.

Arch Otolaryngol Head Neck Surg. 2004 Jan;130(1):78-82.

PMID:
14732773
7.

The impact of functional LIG4 polymorphism on platinum-based chemotherapy response and survival in non-small cell lung cancer.

Jiang YH, Xu XL, Ruan HH, Xu WZ, Li D, Feng JG, Han QB, Mao WM.

Med Oncol. 2014 May;31(5):959. doi: 10.1007/s12032-014-0959-7. Epub 2014 Apr 11.

PMID:
24722796
8.

Prognostic significance of survivin polymorphisms on non-small cell lung cancer survival.

Dai J, Jin G, Dong J, Chen Y, Xu L, Hu Z, Shen H.

J Thorac Oncol. 2010 Nov;5(11):1748-54. doi: 10.1097/JTO.0b013e3181f18cb9.

9.

Two BRM promoter insertion polymorphisms increase the risk of early-stage upper aerodigestive tract cancers.

Wong KM, Qiu X, Cheng D, Azad AK, Habbous S, Palepu P, Mirshams M, Patel D, Chen Z, Roberts H, Knox J, Marquez S, Wong R, Darling G, Waldron J, Goldstein D, Leighl N, Shepherd FA, Tsao M, Der S, Reisman D, Liu G.

Cancer Med. 2014 Apr;3(2):426-33. doi: 10.1002/cam4.201. Epub 2014 Feb 12.

10.

MDM2 SNP309 contributes to non-small cell lung cancer survival in Chinese.

Dong J, Ren B, Hu Z, Chen J, Hu L, Dai J, Jin G, Xu L, Shen H.

Mol Carcinog. 2011 Jun;50(6):433-8. doi: 10.1002/mc.20727. Epub 2011 Jan 25.

PMID:
21268124
11.

SNPs in the TGF-β signaling pathway are associated with increased risk of brain metastasis in patients with non-small-cell lung cancer.

Li Q, Wu H, Chen B, Hu G, Huang L, Qin K, Chen Y, Yuan X, Liao Z.

PLoS One. 2012;7(12):e51713. doi: 10.1371/journal.pone.0051713. Epub 2012 Dec 17.

12.

Active and involuntary tobacco smoking and upper aerodigestive tract cancer risks in a multicenter case-control study.

Lee YC, Marron M, Benhamou S, Bouchardy C, Ahrens W, Pohlabeln H, Lagiou P, Trichopoulos D, Agudo A, Castellsague X, Bencko V, Holcatova I, Kjaerheim K, Merletti F, Richiardi L, Macfarlane GJ, Macfarlane TV, Talamini R, Barzan L, Canova C, Simonato L, Conway DI, McKinney PA, Lowry RJ, Sneddon L, Znaor A, Healy CM, McCartan BE, Brennan P, Hashibe M.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3353-61. doi: 10.1158/1055-9965.EPI-09-0910.

13.

The association of sequence variants in DNA repair and cell cycle genes with cancers of the upper aerodigestive tract.

Hall J, Hashibe M, Boffetta P, Gaborieau V, Moullan N, Chabrier A, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D, Janout V, Fabiánová E, Holcatova I, Hung RJ, McKay J, Canzian F, Brennan P.

Carcinogenesis. 2007 Mar;28(3):665-71. Epub 2006 Oct 13.

14.

Genetic associations of 115 polymorphisms with cancers of the upper aerodigestive tract across 10 European countries: the ARCAGE project.

Canova C, Hashibe M, Simonato L, Nelis M, Metspalu A, Lagiou P, Trichopoulos D, Ahrens W, Pigeot I, Merletti F, Richiardi L, Talamini R, Barzan L, Macfarlane GJ, Macfarlane TV, Holcátová I, Bencko V, Benhamou S, Bouchardy C, Kjaerheim K, Lowry R, Agudo A, Castellsagué X, Conway DI, McKinney PA, Znaor A, McCartan BE, Healy CM, Marron M, Brennan P.

Cancer Res. 2009 Apr 1;69(7):2956-65. doi: 10.1158/0008-5472.CAN-08-2604.

15.

Cyclooxygenase-2 genetic variants are associated with survival in unresectable locally advanced non-small cell lung cancer.

Bi N, Yang M, Zhang L, Chen X, Ji W, Ou G, Lin D, Wang L.

Clin Cancer Res. 2010 Apr 15;16(8):2383-90. doi: 10.1158/1078-0432.CCR-09-2793. Epub 2010 Mar 23.

16.
17.

Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.

Lee Y, Yoon KA, Joo J, Lee D, Bae K, Han JY, Lee JS.

Carcinogenesis. 2013 Feb;34(2):307-13. doi: 10.1093/carcin/bgs356. Epub 2012 Nov 8.

18.

Functional promoter -1271G>C variant of HSPB1 predicts lung cancer risk and survival.

Guo H, Bai Y, Xu P, Hu Z, Liu L, Wang F, Jin G, Wang F, Deng Q, Tu Y, Feng M, Lu D, Shen H, Wu T.

J Clin Oncol. 2010 Apr 10;28(11):1928-35. doi: 10.1200/JCO.2009.24.4954. Epub 2010 Mar 15.

19.

Smoking addiction and the risk of upper-aerodigestive-tract cancer in a multicenter case-control study.

Lee YC, Zugna D, Richiardi L, Merletti F, Marron M, Ahrens W, Pohlabeln H, Lagiou P, Trichopoulos D, Agudo A, Castellsague X, Betka J, Holcatova I, Kjaerheim K, Macfarlane GJ, Macfarlane TV, Talamini R, Barzan L, Canova C, Simonato L, Conway DI, McKinney PA, Thomson P, Znaor A, Healy CM, McCartan BE, Boffetta P, Brennan P, Hashibe M.

Int J Cancer. 2013 Dec 1;133(11):2688-95. doi: 10.1002/ijc.28288. Epub 2013 Jun 21.

20.

Sequence variants of NAT1 and NAT2 and other xenometabolic genes and risk of lung and aerodigestive tract cancers in Central Europe.

McKay JD, Hashibe M, Hung RJ, Wakefield J, Gaborieau V, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Mates D, Foretova L, Janout V, Bencko V, Chabrier A, Hall J, Boffetta P, Canzian F, Brennan P.

Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):141-7. doi: 10.1158/1055-9965.EPI-07-0553.

Items per page

Supplemental Content

Write to the Help Desk